Centralized resource for studying autoimmune diseases and COVID-19 effects
Clinical Characterization and Biorepository Core
['FUNDING_P30'] · OKLAHOMA MEDICAL RESEARCH FOUNDATION · NIH-10911256
This study is gathering health information and samples from around 71,000 people with autoimmune diseases and COVID-19 to help researchers find better treatments and support new scientists in their work.
Quick facts
| Phase | ['FUNDING_P30'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OKLAHOMA MEDICAL RESEARCH FOUNDATION (nih funded) |
| Locations | 1 site (OKLAHOMA CITY, UNITED STATES) |
| Trial ID | NIH-10911256 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a centralized biorepository and clinical characterization core that collects and analyzes data and biospecimens from approximately 71,000 patients with autoimmune diseases and those affected by COVID-19. It aims to provide comprehensive clinical evaluations and facilitate access to a vast array of clinical and experimental data for researchers. By linking clinical data with biospecimens, the project seeks to identify unique molecular phenotypes and responder populations to improve treatment outcomes. The initiative also supports junior investigators by providing mentorship and resources to advance their research careers.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with autoimmune diseases or those who have experienced significant effects from COVID-19.
Not a fit: Patients with unrelated health conditions or those not affected by autoimmune diseases or COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of autoimmune diseases and COVID-19-related complications.
How similar studies have performed: Previous research utilizing centralized biorepositories has shown success in advancing understanding and treatment of complex diseases, indicating a strong potential for this approach.
Where this research is happening
OKLAHOMA CITY, UNITED STATES
- OKLAHOMA MEDICAL RESEARCH FOUNDATION — OKLAHOMA CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MERRILL, JOAN T. — OKLAHOMA MEDICAL RESEARCH FOUNDATION
- Study coordinator: MERRILL, JOAN T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diseases